Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Quick take: The most commonly used blood tests for insulin resistance do not usually “diagnose insulin resistance” directly. Instead, clinicians look for evidence that the body is having trouble managing glucose and related metabolic signals. The core tests are A1C, fasting plasma glucose, and sometimes a 2-hour oral glucose tolerance test. Depending on the situation, a clinician may also order fasting insulin, calculate HOMA-IR, check a lipid panel, and review related markers such as liver enzymes. The American Diabetes Association lists A1C, fasting plasma glucose, and 2-hour plasma glucose during a 75-gram oral glucose tolerance test as appropriate tests for screening and diagnosis of prediabetes and diabetes; these tests reflect different parts of glucose metabolism and may not identify exactly the same people. American Diabetes Association Standards of Care in Diabetes—2026 (doi.org)
What insulin resistance means
Insulin is a hormone made by the pancreas that helps move glucose from the bloodstream into cells for energy use and storage. Insulin resistance means the body’s cells do not respond to insulin as effectively as expected. To keep blood glucose in range, the pancreas may respond by making more insulin. For a period of time, glucose tests can still look normal even though insulin demand is higher than usual.
That is why people often ask for “blood tests for insulin resistance” after seeing normal or borderline A1C results but still having risk factors such as abdominal weight gain, a family history of type 2 diabetes, polycystic ovary syndrome, high triglycerides, low HDL cholesterol, fatty liver disease, or a history of gestational diabetes. The challenge is that insulin resistance is a physiologic state, not a single lab value. Direct measurement methods used in research are not practical for routine medical visits.
The National Institute of Diabetes and Digestive and Kidney Diseases explains that health professionals use blood tests to identify prediabetes by measuring whether glucose is higher than normal, and that cholesterol and triglyceride testing may also be recommended because blood fat levels can rise with insulin resistance or prediabetes. NIDDK: Insulin Resistance & Prediabetes ([niddk.nih.gov](https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance?utm_source=openai))
Which blood tests are commonly used for insulin resistance?
The tests below are commonly used to evaluate insulin resistance risk, prediabetes, diabetes risk, or metabolic patterns associated with insulin resistance. Which ones are appropriate depends on age, symptoms, pregnancy status, medications, prior results, and the clinical question.
| Test | What it measures | Why it may be used | Fasting usually needed? |
|---|---|---|---|
| A1C | Estimated average blood glucose over about the past 2 to 3 months | Convenient screening for prediabetes or diabetes; useful when fasting is difficult | No |
| Fasting plasma glucose | Blood glucose after an overnight fast | Detects impaired fasting glucose, prediabetes, or diabetes-range glucose | Yes |
| Oral glucose tolerance test | Fasting glucose and glucose response after a 75-gram glucose drink | Can detect impaired glucose tolerance that fasting glucose or A1C may miss | Yes |
| Fasting insulin | Insulin level after fasting | May show compensatory hyperinsulinemia; sometimes paired with glucose | Yes |
| HOMA-IR | Calculated estimate from fasting insulin and fasting glucose | Research and selected clinical discussions; not a universal diagnostic standard | Yes |
| Lipid panel | Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides | Looks for metabolic patterns often seen with insulin resistance, especially high triglycerides and low HDL | Sometimes; fasting may be preferred for triglyceride-focused interpretation |
| Comprehensive metabolic panel | Glucose, kidney markers, electrolytes, liver enzymes | May reveal elevated glucose or liver enzyme patterns that prompt follow-up | Varies |
A1C
A1C is often the easiest first-line test because it does not require fasting and reflects longer-term glucose exposure rather than a single moment. It is commonly used for screening and monitoring prediabetes and diabetes. A result from 5.7% to 6.4% is generally considered the prediabetes range, while 6.5% or higher is in the diabetes range when confirmed appropriately. NIDDK recommended tests for identifying prediabetes (niddk.nih.gov)
A normal A1C does not rule out early insulin resistance. If the pancreas is still producing enough extra insulin to hold glucose down, A1C may remain normal. A1C can also be less reliable in certain conditions that affect red blood cells or hemoglobin, including some hemoglobin variants, pregnancy, glucose-6-phosphate dehydrogenase deficiency, HIV, recent blood loss, transfusion, or conditions that change red blood cell turnover. In those situations, the ADA advises using plasma glucose criteria rather than relying only on A1C. ADA Standards of Care in Diabetes—2026 (doi.org)
Fasting plasma glucose
Fasting plasma glucose measures blood sugar after no caloric intake for the required fasting period, often overnight. It is inexpensive, widely available, and part of many metabolic panels. A fasting glucose from 100 to 125 mg/dL is commonly called impaired fasting glucose or prediabetes; 126 mg/dL or higher is in the diabetes range when confirmed. NIDDK diabetes tests and diagnosis (niddk.nih.gov)
This test is useful but not perfect. Some people have normal fasting glucose but abnormal post-meal glucose handling. Others have stress, acute illness, steroid use, sleep disruption, or other factors that temporarily raise glucose. That is why clinicians interpret a single fasting glucose result alongside prior results, symptoms, medications, and sometimes confirmatory testing.
Oral glucose tolerance test
The oral glucose tolerance test, often abbreviated OGTT, measures how the body handles a standardized glucose load. For the common 75-gram adult test, blood is drawn while fasting and again after drinking the glucose solution, typically at 2 hours. A 2-hour value of 140 to 199 mg/dL is in the prediabetes range, and 200 mg/dL or higher is in the diabetes range when confirmed. The NIDDK notes that OGTT can be used to diagnose prediabetes but is less convenient, takes more time, and usually costs more than A1C or fasting glucose. NIDDK: Insulin Resistance & Prediabetes (niddk.nih.gov)
OGTT can be especially informative when symptoms or risk factors seem out of proportion to A1C or fasting glucose, when prior results conflict, or when a clinician wants to evaluate impaired glucose tolerance. It is also used in pregnancy-related glucose testing, though gestational diabetes protocols differ from the standard nonpregnant adult screening approach.
Lipid panel
A lipid panel is not a direct insulin resistance test, but it provides important context. Insulin resistance is commonly associated with a pattern of high triglycerides, low HDL cholesterol, and increased cardiometabolic risk. LDL cholesterol may be normal, high, or appear deceptively unremarkable depending on particle patterns and other factors. A lipid panel also helps guide cardiovascular risk management, which is a major reason clinicians evaluate metabolic health early.
If triglycerides are a major focus, fasting may be preferred. If the test is part of routine cardiovascular screening, some clinicians accept nonfasting lipids. Follow the ordering instructions because repeat fasting testing may be requested if triglycerides are high or the result does not fit the clinical picture.
Comprehensive metabolic panel and liver enzymes
A comprehensive metabolic panel may include glucose plus liver and kidney markers. It is not designed specifically to diagnose insulin resistance, but it may reveal elevated fasting glucose or liver enzyme patterns that lead to further testing. Insulin resistance is closely related to metabolic dysfunction-associated steatotic liver disease, commonly called fatty liver disease, although liver enzymes can be normal even when fatty liver is present.
Blood glucose and A1C result ranges commonly used
The following table summarizes commonly used U.S. clinical thresholds for nonpregnant adults. These ranges are for screening and diagnosis of prediabetes or diabetes, not for diagnosing insulin resistance itself. In the absence of clear symptoms or a hyperglycemic crisis, diabetes-range results generally require confirmation with repeat testing or another diagnostic test. The ADA emphasizes confirmatory testing when hyperglycemia is not unequivocal. ADA Standards of Care in Diabetes—2026 (doi.org)
| Test | Normal range | Prediabetes range | Diabetes range |
|---|---|---|---|
| A1C | Below 5.7% | 5.7% to 6.4% | 6.5% or higher |
| Fasting plasma glucose | Below 100 mg/dL | 100 to 125 mg/dL | 126 mg/dL or higher |
| 2-hour OGTT glucose | Below 140 mg/dL | 140 to 199 mg/dL | 200 mg/dL or higher |
Fasting insulin, HOMA-IR, and why they are different from glucose tests
Many people looking for blood tests for insulin resistance are really looking for a way to detect elevated insulin before glucose becomes abnormal. That is understandable: insulin levels may rise as the pancreas compensates for reduced insulin sensitivity. A fasting insulin test can sometimes provide useful context, especially when paired with fasting glucose.
MedlinePlus explains that if insulin is high while blood glucose is normal or only slightly above a person’s usual level, insulin resistance may be one possible explanation. MedlinePlus: Insulin in Blood (<a href=”https://medlineplus.gov/lab-tests/insulin-in-blood/” class=”ctx-inline-source” rel=”noopener”>medlineplus</a>.gov)However, fasting insulin is not interpreted like A1C or fasting glucose. There is no universally accepted cutoff that cleanly separates insulin-sensitive from insulin-resistant people across all ages, body sizes, ethnic backgrounds, lab methods, and clinical settings.
HOMA-IR, short for homeostatic model assessment of insulin resistance, is a calculation that uses fasting glucose and fasting insulin. A common U.S. formula is:
HOMA-IR = fasting insulin (µIU/mL) × fasting glucose (mg/dL) ÷ 405
When glucose is reported in mmol/L, a common formula is fasting insulin multiplied by fasting glucose divided by 22.5. HOMA-IR is widely used in research and may be discussed in some clinical settings, but it is not a universally standardized diagnostic test. Cutoffs vary by study population and insulin assay, and results can be misleading if the fasting sample was not truly fasting or if glucose and insulin physiology is affected by medications, acute illness, pregnancy, or pancreatic beta-cell dysfunction.
The Endocrine Society has noted that directly measuring insulin resistance with methods such as the hyperinsulinemic-euglycemic clamp is too difficult for routine clinical practice, and that using fasting insulin as a proxy is complicated by physiology and lack of measurement standardization across studies. Endocrine Society clinical practice guideline on metabolic risk (academic.oup.com)
Should you ask for fasting insulin?
Fasting insulin may be reasonable to discuss if you have strong risk factors for insulin resistance, unexplained metabolic changes, PCOS, a family history of type 2 diabetes, prior gestational diabetes, or discordant glucose results. It may also be used by some clinicians to track changes over time when lifestyle or medication interventions are being considered. But fasting insulin should not be used alone to diagnose yourself or to decide treatment without clinical interpretation.
What about LP-IR and advanced lipoprotein testing?
Some specialty labs offer an insulin resistance score based on lipoprotein particle patterns, sometimes called LP-IR. This is not the same as fasting insulin or HOMA-IR. It estimates insulin-resistance-related patterns in lipoproteins, and it generally requires a fasting sample for accurate interpretation. These tests may be useful in selected cardiovascular or metabolic evaluations, but they are not the standard first step for most people. If considering advanced testing, compare whether the result would change management, whether insurance covers it, and whether a clinician is prepared to interpret it.
Who should consider testing?
Screening decisions should be individualized, but several major organizations recommend glucose-based screening for people at increased risk. The U.S. Preventive Services Task Force recommends screening asymptomatic adults ages 35 to 70 years who have overweight or obesity for prediabetes and type 2 diabetes, and offering or referring people with prediabetes to effective preventive interventions. USPSTF recommendation statement (uspreventiveservicestaskforce.org)
Testing may also be discussed earlier or more often when risk factors are present, such as a first-degree relative with diabetes, history of gestational diabetes, PCOS, high blood pressure, abnormal cholesterol or triglycerides, cardiovascular disease, fatty liver disease, certain high-risk medications, or symptoms such as increased thirst, frequent urination, blurry vision, unexplained weight change, recurrent infections, or slow wound healing.
How to prepare for insulin resistance-related blood tests
Preparation depends on the test ordered. For A1C, fasting is usually not required. For fasting plasma glucose, fasting insulin, HOMA-IR, many triglyceride-focused lipid panels, and OGTT, fasting is usually required. A common instruction is to avoid calories for 8 to 12 hours and drink only water, but you should follow the specific instructions from the lab or clinician.
- Ask whether to fast. Do not assume every panel has the same rules.
- Take medications as directed. Do not stop diabetes, blood pressure, steroid, thyroid, psychiatric, or hormonal medications unless the ordering clinician tells you to.
- Avoid unusual exercise or alcohol before testing if your clinician advises it, because these can affect glucose or triglycerides in some people.
- For OGTT, plan extra time. You may be at the lab for more than 2 hours and may need to remain seated between blood draws.
- Tell the clinician if you are ill. Acute illness, infection, poor sleep, and significant stress can affect glucose results.
Limitations: what these tests can and cannot tell you
Insulin resistance exists on a spectrum. A1C, fasting glucose, and OGTT are excellent for identifying abnormal glucose regulation, but they do not measure how hard the pancreas is working to keep glucose controlled. Fasting insulin and HOMA-IR move closer to the insulin-resistance question, but their interpretation is less standardized. Lipid panels and liver enzymes provide cardiometabolic context, not a direct diagnosis.
Another limitation is that different tests may disagree. NIDDK notes that the recommended prediabetes tests do not always identify the same patients; for example, one person may have normal fasting glucose but an A1C in the prediabetes range. NIDDK recommended tests for identifying prediabetes (niddk.nih.gov)This is not necessarily a lab error. A1C, fasting glucose, and OGTT each capture different aspects of glucose metabolism.
Cost and access considerations
For many people, the lowest-friction path is to ask a primary care clinician which glucose and metabolic tests are appropriate. A1C, fasting glucose, lipid panel, and comprehensive metabolic panel are widely available and often part of routine preventive or chronic-care lab work when medically indicated. Insurance coverage depends on plan rules, diagnosis codes, preventive-care criteria, deductibles, and network status.
If you are comparing self-pay lab options, compare the effective total cost, not just the advertised test price. Look for whether the price includes clinician authorization when required, specimen collection or draw fees, processing fees, follow-up review, taxes where applicable, and whether repeat or confirmatory testing would cost extra. Also confirm whether the test is available in your state, whether fasting is required, where the blood draw can be completed, and how results are delivered.
In general, A1C and fasting glucose are simpler and often less expensive than an OGTT. OGTT usually takes longer and requires more lab time. Fasting insulin, HOMA-IR bundles, and advanced lipoprotein insulin-resistance scores may be more variable in availability and insurance coverage.
Practical next steps after results
If your results are normal but risk factors are present, ask how often you should be rechecked and whether lifestyle interventions are recommended now. If one result is borderline, your clinician may repeat the test, order a different glucose test, or review factors that could have affected the result. If results fall in the prediabetes range, the next step is usually a prevention plan focused on nutrition, physical activity, weight management when appropriate, sleep, blood pressure, cholesterol, and follow-up testing. If results are in the diabetes range, confirmation and prompt clinical follow-up are important.
Questions worth asking include:
- Which result is most important in my situation: A1C, fasting glucose, OGTT, insulin, or lipids?
- Do any medications or health conditions make A1C less reliable for me?
- Should this result be repeated or confirmed?
- Would fasting insulin or HOMA-IR change what we do next?
- What target changes should we track over the next 3 to 6 months?
FAQs
What is the best blood test for insulin resistance?
There is no single best routine test for everyone. A1C, fasting plasma glucose, and OGTT are the most established tests for identifying prediabetes and diabetes risk. Fasting insulin and HOMA-IR can add information in selected cases, but they are not standardized enough to serve as universal diagnostic tests.
Can A1C be normal if you have insulin resistance?
Yes. Early insulin resistance can be present while A1C remains normal because the pancreas may compensate by producing more insulin. A1C measures average glucose exposure, not how much insulin was required to achieve that glucose level.
Is fasting insulin worth testing?
Sometimes. Fasting insulin can help show whether insulin levels are higher than expected for the glucose level, but interpretation is not standardized across all laboratories and populations. It is most useful when the ordering clinician has a clear reason for ordering it and a plan for interpreting the result.
What is a normal HOMA-IR?
There is no single universally accepted “normal” HOMA-IR cutoff. Values vary by population, insulin assay, age, body composition, and clinical context. If HOMA-IR is calculated, it should be interpreted by a clinician rather than compared with a generic internet cutoff.
Does an oral glucose tolerance test show insulin resistance?
An OGTT shows how your glucose changes after a standardized glucose drink. A standard OGTT does not necessarily measure insulin levels unless insulin is ordered at the same time. Even without insulin measurements, an abnormal 2-hour glucose result can reveal impaired glucose tolerance that may be missed by fasting glucose alone.
What labs are often abnormal with insulin resistance?
Common patterns can include fasting glucose in the prediabetes range, A1C in the prediabetes range, elevated triglycerides, low HDL cholesterol, and sometimes elevated liver enzymes. Some people with insulin resistance have normal routine labs early on.
Do home glucose monitors diagnose insulin resistance?
No. Home glucose meters and continuous glucose monitors can show glucose patterns, but they do not directly measure insulin sensitivity and should not be used alone to diagnose prediabetes, diabetes, or insulin resistance. Abnormal home readings should be discussed with a clinician and confirmed with appropriate laboratory testing.
Sources
- American Diabetes Association: Standards of Care in Diabetes—2026, Diagnosis and Classification of Diabetes
- NIDDK: Insulin Resistance & Prediabetes
- NIDDK: Recommended Tests for Identifying Prediabetes
- NIDDK: Diabetes Tests & Diagnosis
- U.S. Preventive Services Task Force: Screening for Prediabetes and Type 2 Diabetes
- MedlinePlus: Insulin in Blood
- Endocrine Society Clinical Practice Guideline: Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk
